UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 612

Sortiert nach

Relationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans

Molecular psychiatry, 2013-11, Vol.18 (11), p.1199-1204

2013

Link zum Volltext

Verfügbarkeit prüfen

Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology

Molecular psychiatry, 2012-07, Vol.17 (7), p.664-665

2012

Link zum Volltext

Verfügbarkeit prüfen

Antidepressant effects of ketamine in depressed patients

Biological psychiatry (1969), 2000-02, Vol.47 (4), p.351-354

2000

Link zum Volltext

Verfügbarkeit prüfen

First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients

Molecular psychiatry, 2006-02, Vol.11 (2), p.118-119

2006

Link zum Volltext

Verfügbarkeit prüfen

Linking in vivo brain serotonin type 1B receptor density to phenotypic heterogeneity of posttraumatic stress symptomatology

Molecular psychiatry, 2013-04, Vol.18 (4), p.399-401

2013

Link zum Volltext

Verfügbarkeit prüfen

Capturing the angel in "angel dust": twenty years of translational neuroscience studies of NMDA receptor antagonists in animals and humans

Schizophrenia bulletin, 2012-09, Vol.38 (5), p.942-949

2012

Link zum Volltext

Verfügbarkeit prüfen

Characterizing thalamo-cortical disturbances in schizophrenia and bipolar illness

Cerebral cortex (New York, N.Y. 1991), 2014-12, Vol.24 (12), p.3116-3130

2014

Link zum Volltext

Verfügbarkeit prüfen

Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments

Molecular psychiatry, 2002, Vol.7 Suppl 1 (S1), p.S71-S80

2002

Link zum Volltext

Verfügbarkeit prüfen

Ketamine-induced reduction in mGluR5 availability is associated with an antidepressant response: an [ 11 C]ABP688 and PET imaging study in depression

Molecular psychiatry, 2018-04, Vol.23 (4), p.824-832

2018

Link zum Volltext

Verfügbarkeit prüfen

Naltrexone in the Treatment of Alcohol Dependence

The New England journal of medicine, 2001-12, Vol.345 (24), p.1734-1739

2001

Link zum Volltext

Verfügbarkeit prüfen

Toward a neurobiology of delusions

Progress in neurobiology, 2010-11, Vol.92 (3), p.345-369

2010

Link zum Volltext

Verfügbarkeit prüfen

Memantine, an NMDA receptor antagonist, differentially influences Go/No-Go performance and fMRI activity in individuals with and without a family history of alcoholism

Psychopharmacologia, 2012-07, Vol.222 (1), p.129-140

2012

Link zum Volltext

Verfügbarkeit prüfen

Ethanol-like effects of thiopental and ketamine in healthy humans

Journal of psychopharmacology (Oxford), 2010-02, Vol.24 (2), p.203-211

2010

Link zum Volltext

Verfügbarkeit prüfen

Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder

The American journal of psychiatry, 1997-05, Vol.154 (5), p.624-629

1997

Link zum Volltext

Verfügbarkeit prüfen

Transcranial magnetic stimulation and auditory hallucinations in schizophrenia

The Lancet (British edition), 2000-03, Vol.355 (9209), p.1073-1075

2000

Link zum Volltext

Verfügbarkeit prüfen

Single Photon Emission Computerized Tomography Imaging of Amphetamine-Induced Dopamine Release in Drug-Free Schizophrenic Subjects

Proceedings of the National Academy of Sciences - PNAS, 1996-08, Vol.93 (17), p.9235-9240

1996

Link zum Volltext

Verfügbarkeit prüfen

Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action

Biological psychiatry (1969), 1999-07, Vol.46 (2), p.212-220

1999

Link zum Volltext

Verfügbarkeit prüfen

Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS)

Journal of traumatic stress, 1998-01, Vol.11 (1), p.125-136

1998

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of iclepertin (BI 425809) in patients with schizophrenia: CONNEX, a Phase III randomised controlled trial programme

European psychiatry, 2023-03, Vol.66 (S1), p.S637-S637

2023

Link zum Volltext

Verfügbarkeit prüfen

Transcranial magnetic stimulation of left temporoparietal cortex in three patients reporting hallucinated “voices”

Biological psychiatry (1969), 1999-07, Vol.46 (1), p.130-132

1999

Link zum Volltext

Verfügbarkeit prüfen

Probing the Pathophysiology of Auditory/Verbal Hallucinations by Combining Functional Magnetic Resonance Imaging and Transcranial Magnetic Stimulation

Cerebral cortex (New York, N.Y. 1991), 2007-11, Vol.17 (11), p.2733-2743

2007

Link zum Volltext

Verfügbarkeit prüfen

Anterior hippocampal dysconnectivity in posttraumatic stress disorder: a dimensional and multimodal approach

Translational psychiatry, 2017-02, Vol.7 (2), p.e1045-e1045

2017

Link zum Volltext

Verfügbarkeit prüfen

Quantitative Morphology of the Caudate and Putamen in Patients With Cocaine Dependence

The American journal of psychiatry, 2001-03, Vol.158 (3), p.486-489

2001

Link zum Volltext

Verfügbarkeit prüfen

Genome-wide significant loci for addiction and anxiety

European psychiatry, 2016-08, Vol.36, p.47-54

2016

Link zum Volltext

Verfügbarkeit prüfen

NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development

Psychopharmacology, 2003-09, Vol.169 (3-4), p.215-233

2003

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 612

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(553)
Mit Volltextzugriff
(524)

Publikationsform

Sprache

Englisch
(611)
Japanisch
(111)
Chinesisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(476)
Life Sciences & Biomedicine
(446)
Humans
(389)
Psychiatry
(263)
Male
(235)
Adult
(201)
Female
(201)
Biological And Medical Sciences
(195)
Medical Sciences
(180)
Neurosciences & Neurology
(169)
Neurosciences
(161)
Middle Aged
(123)
Psychology. Psychoanalysis. Psychiatry
(117)
Psychopathology. Psychiatry
(90)
Pharmacology & Pharmacy
(84)
Adult And Adolescent Clinical Studies
(78)
Animals
(77)
Ptsd
(69)
Double-Blind Method
(59)
Schizophrenia
(58)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Relationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans

Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology

Antidepressant effects of ketamine in depressed patients

First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients

Linking in vivo brain serotonin type 1B receptor density to phenotypic heterogeneity of posttraumatic stress symptomatology

Capturing the angel in "angel dust": twenty years of translational neuroscience studies of NMDA receptor antagonists in animals and humans

Characterizing thalamo-cortical disturbances in schizophrenia and bipolar illness

Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments

Ketamine-induced reduction in mGluR5 availability is associated with an antidepressant response: an [ 11 C]ABP688 and PET imaging study in depression

Naltrexone in the Treatment of Alcohol Dependence

Toward a neurobiology of delusions

Memantine, an NMDA receptor antagonist, differentially influences Go/No-Go performance and fMRI activity in individuals with and without a family history of alcoholism

Ethanol-like effects of thiopental and ketamine in healthy humans

Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder

Transcranial magnetic stimulation and auditory hallucinations in schizophrenia

Single Photon Emission Computerized Tomography Imaging of Amphetamine-Induced Dopamine Release in Drug-Free Schizophrenic Subjects

Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action

Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS)

Efficacy and safety of iclepertin (BI 425809) in patients with schizophrenia: CONNEX, a Phase III randomised controlled trial programme

Transcranial magnetic stimulation of left temporoparietal cortex in three patients reporting hallucinated “voices”

Probing the Pathophysiology of Auditory/Verbal Hallucinations by Combining Functional Magnetic Resonance Imaging and Transcranial Magnetic Stimulation

Anterior hippocampal dysconnectivity in posttraumatic stress disorder: a dimensional and multimodal approach

Quantitative Morphology of the Caudate and Putamen in Patients With Cocaine Dependence

Genome-wide significant loci for addiction and anxiety

NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development

Suchergebnisse filtern